Preparation of composite motidine dispersant pills
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 金日制药(中国)有限公司
- Publication Date
- 2003-11-19
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to the technical field of western medicine dispersible tablets, especially the preparation method of compound famotidine dispersible tablets. Background technique
[0002] Dispersible tablets are a commonly used pharmaceutical dosage form. According to the relevant drug laws and regulations of our country, changing the dosage form is regarded as a new drug research. The original dosage form is compound famotidine chewable tablet, which was approved by the U.S. FDA in 2000 by Johnson & Johnson-Merck. In China, this variety is applying for clinical trial research. Its characteristic is that it can take effect quickly and maintain the curative effect for a long time. The tablet is easy to swallow after chewing, accelerates disintegration, and improves curative effect. However, there is a single way of taking it, and its taste may make some patients dissatisfied. Dispersible tablets can be swallowed like ordinar...